Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for ZBH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 447.80M
March 31, 2026 359.40M
December 31, 2025 517.40M
September 30, 2025 418.70M
June 30, 2025 378.20M
March 31, 2025 382.80M
December 31, 2024 506.30M
September 30, 2024 395.70M
June 30, 2024 369.40M
March 31, 2024 228.00M
December 31, 2023 588.40M
September 30, 2023 337.60M
June 30, 2023 347.90M
March 31, 2023 307.70M
December 31, 2022 244.20M
September 30, 2022 450.80M
June 30, 2022 352.50M
March 31, 2022 237.20M
December 31, 2021 365.70M
September 30, 2021 433.10M
June 30, 2021 453.90M
March 31, 2021 246.50M
December 31, 2020 425.10M
September 30, 2020 381.30M
June 30, 2020 -52.80M
Date Value
March 31, 2020 450.90M
December 31, 2019 423.30M
September 30, 2019 577.90M
June 30, 2019 301.00M
March 31, 2019 283.60M
December 31, 2018 379.50M
September 30, 2018 484.10M
June 30, 2018 393.30M
March 31, 2018 490.50M
December 31, 2017 402.90M
September 30, 2017 463.50M
June 30, 2017 440.50M
March 31, 2017 275.40M
December 31, 2016 627.20M
September 30, 2016 352.60M
June 30, 2016 379.60M
March 31, 2016 272.80M
December 31, 2015 420.20M
September 30, 2015 151.30M
June 30, 2015 186.80M
March 31, 2015 91.50M
December 31, 2014 354.20M
September 30, 2014 255.70M
June 30, 2014 254.10M
March 31, 2014 188.80M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 1.061B
Stryker Corp. 1.261B
Globus Medical, Inc. 209.74M
Solventum Corp. 227.00M
Boston Scientific Corp. 1.474B